Pulmonary Formulations: What Remains to be Done?, J Aerosol Med Pulm Drug Deliv, vol.23, 2010. ,
La délivrance pulmonaire : une nouvelle voie d'accès pour les médicaments-état de l'art, réalisations et perspectives. Académie royale de Médecine de Belgique, 2014. ,
Drug Delivery: Pulmonary Delivery. Encyclopedia of Pharmaceutical Technology, pp.1279-1286, 2007. ,
Development of Dry Powder Inhalers. Recent Pat Drug DelivFormul, vol.1, pp.11-21, 2007. ,
Predicting Extrathoracic Deposition from Dry Powder Inhalers, Aerosol sci, vol.35, pp.309-331, 2004. ,
Capsule and Device: An Imperative Menage a Trois for Respirable Dry Powders, Int J Pharm, vol.494, pp.40-48, 2015. ,
The Kinetic of Cohesive Powder De-agglomeration from Three Inhaler Devices, Int J Pharm, vol.421, pp.72-81, 2011. ,
CFD-DEM investigation of the Dispersion Mechanisms in Commercial Dry Powder Inhalers, Powder Technol, vol.240, pp.19-24, 2013. ,
Three-dimensional DEM-CFD analysis of air-flow induced detachment of API particles from carrier particles in dry powder inhalers, Acta Pharm Sin B, 2014. ,
Fluid flow and particle deposition analysis in a realistic extrathoracic airway model using unstructured grids, Aerosol Sci, vol.38, pp.494-508, 2007. ,
Numerical analysis of micro-and nano-particle deposition in a realistic human upperairway, ComputBiol Med, vol.42, pp.39-49, 2012. ,
Predicting Extrathoracic Deposition from Dry Powder Inhalers, Aerosol sci, vol.35, pp.309-331, 2004. ,
Simulations lagrangiennes d'écoulements de poudre pour inhalation dans la tuyère de l'impacteur en cascade Andersen *Thèse+. *Faculté de Pharmacie+: Université Henry Poincaré-Nancy 1, 2007. ,
Etude des paramètres influençant le transport des aérosols solides médicamenteux dans les voies respiratoires supérieures : application à la tuyère d'admission de la Pharmacopée, 2014. ,
Pulmonary Drug Delivery. Part I: Physiological Factors affecting Therapeutic Effectiveness of Aerosolized Medications, Br J ClinParmacol, vol.56, pp.588-599, 2003. ,
Temozolomide-Based Dry Powder Formulations of Lung TumorRelated Inhalation Treatment, Pharm Res, vol.28, pp.762-775, 2011. ,
Feasability of Haloperidol-Anchroed Albumin Nanoparticles Loaded with Doxorubicin as Dry Powder Inhaler for Pulmonary Delivery, Pharm Dev Technol, vol.20, pp.183-196, 2015. ,
La phase d'absorption des médicaments. Bases fondamentales en pharmacologie, 2014. ,
Aerosol Technology : Properties, Behavior, and Measurement of Airborne Particles, 1999. ,
Granulométrie des particules en mouvement et des aérosols, 1995. ,
Interet des Données de Remboursement de l'Assurance-Maladie pour l'Etude des Disparités Territoriales de la Prévalence de l'Asthme. Revue d'Epidemiologie et de Santé Publique, pp.155-162, 2012. ,
Définition et Diagnostic de l'Asthme, 2013. ,
Epidémiologie de l'Asthme chez la Femme au Cours de la Vie, Rev Mal Respir, vol.7, pp.98-100, 2015. ,
Pneumopathie Chronique Obstructive, Consulté en ligne le 06/07/2016 à l'adresse, 2015. ,
La Broncho Pneumopathie Chronique Obstructive, 2016. ,
Médicaments Administrés par Voie Nasale, Bronchodilatateurs de Très Longue Durée d'Action et Aerosolthérapie, 2014. ,
, , 2016.
Nébuliseur à tamis vibrant Geratherm®, 2016. ,
Aérosol Nébuliseur Ultrasonique Omron U17®, 2016. ,
Evolution of Dry Powder Inhaler Design, Formulation and Performance, Respir Med, vol.96, pp.293-304, 2002. ,
Cohésion par Capillarité et Comportement Mécanique en Milieu Granulaires, 2005. ,
Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate 2. IpratropiumBromide Monohydrate and FluticasonePropionate, J PharmSci, vol.99, pp.3415-3429, 2010. ,
Dry Powder Inhaler Formulation, Respir Care, vol.50, issue.9, pp.1209-1236, 2005. ,
Importance of Particle Size and Shape on the Tensile Strength Distribution and De-agglomeration of Cohesive Powders, Powder Technol, vol.249, pp.297-203, 2013. ,
The Kinetic of Cohesive Powder De-agglomeration from Three Inhaler Devices, Int J Pharm, vol.421, pp.72-81, 2011. ,
Three-dimensional DEM-CFD analysis of air-flow induced detachment of API particles from carrier particles in dry powder inhalers, Acta Pharm Sin B, 2014. ,
Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate 1. Albuterol Sulfate and Disodium Cromoglycate, J Pharm Sci, vol.99, pp.3415-3429, 2010. ,
Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate 2. Ipatropium Bromide Monohydrate and Fluticasone Propionate, J Pharm Sci, vol.99, pp.3415-3429, 2010. ,
Dry powder aerosols generated by standardized entrainment tubes from alternative sugar blends: 3.Trehalose dihydrate and D-mannitol carriers, J Pharm Sci, vol.99, pp.3430-3441, 2010. ,
The Influence of Fine Excipient Particles on the Performance of CarrierBased Dry Powder Inhalation Formulations, Pharm Res, vol.23, issue.8, 2006. ,
New Mechanisms to Explain the Effects of Added Lactose Fines on the Dispersion Performance of Adhesive Mixtures for Inhalation, PLoS ONE, vol.9, issue.1, 2014. ,
Lactose Characteristics and the Generation of the Aerosol, Adv Drug Deliv Rev, vol.64, pp.233-56, 2012. ,
Effects of Particles Size and Adding Sequence of Fine Lactose on the Deposition of Salbutamol Sulphate from Dry Powder Formulation, Int J Pharm, vol.182, pp.133-177, 1999. ,
Development of Dry Powder Inhalers. Recent Pat Drug DelivFormul, vol.1, pp.11-21, 2007. ,
Dry Powder Aerosols: Emerging Technologies. Encyclopedia of Pharmaceutical Technology. thirdedition. James Swarbrick, pp.1428-1463, 2007. ,
Formation of aqueous small droplet aerosols assisted by supercritical carbon dioxide, AerosolSciTechnol, vol.30, issue.1, pp.3-15, 1999. ,
, Préparation pour inhalation, p.18
In vitro, in vivo and ex vivo models for studying particle deposition and drug absorption of inhaled pharmaceuticals, Eur J PharmSci, vol.49, pp.805-823, 2013. ,
Pulmonary Drug Delivery from the Taifun Dry Powder Inhaler is Relatively Independant of the Patient's Inspiratory Effort, J Aerosol Med, vol.10, pp.97-104, 2000. ,
Introduction to CFD Methodology. Fluent User's Guide, 2010. ,
Phénomènes de Transport et leurs Résolutions Numériques. Editions Polytechnica, p.356, 1993. ,
Introduction to CFD Basics. Cornell Online Course, 2012. ,
Fluent Theory Guide. Fluent User's Guide, 2013. ,
Regional Aerosol Deposition and Flow Measurements in an Idealized Mouth and Throat, Aerosol Sci, vol.35, pp.21-32, 2004. ,
Fluid Flow and Particle Deposition Analysis in a Realistic Extrathoracic Airway Model using Unstructured Grids, Aerosol Sci, vol.38, pp.494-508, 2007. ,
Aerosol Deposition in the Extrathoracic Region, Aerosol Sci Technol, vol.37, pp.659-71, 2003. ,
The Use of Computational Approaches in Inhaler Development, Adv Drug Deliv Rev, vol.64, pp.312-334, 2012. ,
Mécanique des Fluides. Site web ,
Mécanique des fluides, 1968. ,
Drag Coefficient and Terminal Velocity of Spherical and Nonspherical Particles, Powder Technol, vol.58, pp.63-70, 1989. ,
Insight into Pressure Drop Dependant Efficiencies of Dry Powder Inhalers, vol.46, pp.142-148, 2012. ,
Assessing dry powder inhalers, 2010. ,
Drug Delivery to the Respiratory Tract using Dry Powder Inhalers, Int J Parm, vol.101, pp.1-13, 1994. ,
In Vitro Evaluation of Dry Powder Inhalers I: Drug Deposition of Commonly used Devices, Int J Pharm, vol.154, pp.19-29, 1997. ,
The 'Stage by Stage' Deposition of Drugs from Commercial Single-Active and Combination Dry Powder Inhaler Formulations, vol.43, pp.225-235, 2011. ,
Developing an Efficient and Reliable Dry Powder Inhaler for Pulmonary Drug Delivery-A Review for Multidisciplinary Researchers, Medical Engineerigng and Physics, vol.34, pp.409-427, 2012. ,
The Influence of Carrier Roughness on Adhesion, Content Uniformity and the In Vitro Depostion of TerbutalineSulphate from Dry Powder Inhalers, Int J Pharm, vol.275, pp.201-209, 2004. ,
Aerodynamic Depostion of Combination Dry Powder Formulation in Vitro: A Comparison of Three Impactors, Int J Pharm, vol.388, pp.40-51, 2010. ,
Comparaison of Bronchodilatator Responses and Deposition Patters of Salbutamol Inhaled from a Pressurised Metered Dose Inhaler, as a Dry Powder, and as a Nebulised Solution, Thorax, vol.45, pp.469-473, 1990. ,
Drug Delivery to the Respiratory Tract using Dry Powder Inhalers, Int J Parm, vol.101, pp.1-13, 1994. ,
A Compaison of the Lung Deposition of Budesonide from Easyhaler, Turbuhaler and pMDI plus spacer in asthmatic patients, Respiratory medicine, vol.95, pp.720-727, 2001. ,
Pulmonary Drug Delivery by Powder Aerosols, Journal of Controlled Release, vol.194, pp.228-240, 2014. ,
Variability in Lung Deposition of Inhaled Drug, within and between Asthmatic Patients, with a pMDI and a Dry Powder Inhaler, Turbuhaler, Int J Pharm, vol.193, pp.227-230, 2000. ,
Effects of Oral Airway Geometry Characteristics on the Diffusional Deposition of Inhaled Nanoparticles, J Biomech Eng, vol.130, issue.1, 2008. ,
, Contours et vecteurs obtenus
, Contours de vitesse (en m/s) de la phase continue pour un débit de 60 L/min Vecteurs vitesse (en m/s) de la phase continue pour un débit de 60 L/min